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Penicillin-binding proteins (PBPs) of slightly different molecular masses (94, 62 or 68, 42 or 50, 25, and 22
kDa) were identified in one human and two porcine Brachyspira pilosicoli strains. Identification of PBPs of B.
pilosicoli provides a basis for characterization of the genes encoding these proteins among pathogenic intestinal
spirochetes of humans and animals.
Brachyspira pilosicoli is a spirochete that colonizes the hind-
gut of a broad range of vertebrate hosts, including humans (5).
In all hosts where it is found, B. pilosicoli is associated with
colonic spirochetosis (CS), a polymicrobial disease character-
ized by epithelial attachment of Brachyspira spirochetes alone
or together with certain Helicobacter species and accompanied
by damage and inflammation of the gut wall (5, 7). B. pilosicoli
is widespread in stool specimens obtained from humans in
developing countries, whereas in Western societies, it is found
primarily among homosexual men and human immunodefi-
ciency virus-infected patients, some with diarrhea, abdominal
pain, and rectal bleeding (16). The systemic spread of B. pi-
losicoli has been documented by culture of blood specimens
obtained from critically ill human patients, some with diarrheal
disease suggestive of CS (13, 22).
A variable response to parenteral administration of -lactam
antibiotics has been recorded for patients with the enteric (3,
14) and systemic (13, 15) forms of CS. More recently, an
assessment of the in vitro antimicrobial susceptibility of a large
collection of human and porcine B. pilosicoli isolates revealed
variable sensitivities to -lactam antibiotics (2). The MIC of
the aminobenzylpenicillin amoxicillin was between 0.25 and
128 g/ml, whereas those of the cephalosporin ceftriaxone and
the carbapenem meropenem were between 0.125 and 2 g/ml
and 0.125 and 0.5 g/ml, respectively.
Penicillin-binding proteins (PBPs) are a group of enzymes
anchored to the inner membrane of bacteria that catalyze the
terminal stage of cell wall peptidoglycan synthesis (20). The
PBPs of Escherichia coli have been classified as either high-
molecular-weight (HMW) PBP-1a, PBP-1b, PBP-1c, PBP-2,
and PBP-3, which exhibit transpeptidase and transglycosylase
activities, or low-molecular-weight PBP-4, PBP-5/6, and
PBP-7, which display endopeptidase and carboxypeptidase ac-
tivities (10, 20). With the exception of the transglycosylases,
these enzymes are inhibited by covalent binding of -lactam
antibiotics, leading to the lysis of susceptible bacteria (10).
Therefore, -lactam antibiotics are substrate analogs that bind
irreversibly to the active site of the PBPs (8, 10, 20).
PBPs have been identified among certain pathogenic spiro-
chetes, including Treponema pallidum, the syphilis spirochete,
Borrelia burgdorferi, the Lyme disease spirochete, and Lepto-
spira interrogans, the cause of leptospirosis (1, 18, 19). By con-
trast, relatively little is known about the function of membrane
proteins of Brachyspira intestinal spirochetes, and with the
exception of one report in which PBPs were used as a tool to
verify the purity of outer membrane preparations from B.
pilosicoli (23), the PBPs of intestinal spirochetes have not been
characterized. The purpose of the present study was to exam-
ine B. pilosicoli for the presence of PBPs and comparison with
known PBPs of E. coli.
(A preliminary report of these findings was presented at the
84th Annual Meeting of the Conference of Research Workers
in Animal Diseases, St. Louis, Mo., 9 to 11 November 2003
[R. P. Dassanayake, G. Sarath, and G. E. Duhamel, abstr.
55P].)
B. pilosicoli strain SP16 (ATCC 49776) (6, 21), originally
isolated from a diarrheal specimen obtained from a human
immunodeficiency virus-positive individual (12), was propa-
gated in prereduced anaerobically sterilized trypticase soy
broth, as previously described (4). The reference porcine B.
pilosicoli strain P43/6/78T (ATCC 51139) (6, 21) and the field
strain UNL-8 (5) were included in some experiments. E. coli
K-12 (Gene Choice, Frederick, Md.) was grown at 37°C in
Luria-Bertani medium.
Bacterial membranes were prepared as previously described
(24). Briefly, bacteria grown to the exponential phase were
harvested by centrifugation, and the cell pellet was washed
with phosphate-buffered saline (pH 7.2). After the addition of
lysis buffer (10 mM Tris-HCl, 1 mM EDTA, and 1 mM PMSF
[pH 7.2]) and sonication (six pulses of 30 s at 50% duty cycle)
of the mixture, the cellular debris were removed by centrifu-
gation and the supernatant was centrifuged at 100,000  g for
60 min at 4°C. The pellet containing the membrane fraction
was washed with phosphate-buffered saline, and after determi-
nation of the protein concentration (Pierce, Rockford, Ill.), the
membrane portion was adjusted to 10 mg/ml.
Ampicillin sodium salt (Sigma Chemical Co., St. Louis, Mo.)
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and digoxigenin-NHS ester (Roche Applied Science, Indianap-
olis, Ind.) were conjugated, and digoxigenin-ampicillin conju-
gates (DIG-AMP) were purified by gel filtration, as previously
described (11, 24). Detection of PBPs with DIG-AMP was
accomplished as previously described (20, 24). Briefly, mem-
brane preparations from either B. pilosicoli or E. coli (100 g)
were incubated with 2.5 g of DIG-AMP (15 mM) for 10 min
at 30°C. After the reaction was stopped by the addition of 5 g
of unlabeled ampicillin and 5 l of 20% (wt/vol) Sarkosyl
(Sigma), the Sarkosyl-soluble material was mixed with an equal
volume of sample loading buffer, boiled for 5 min, separated by
electrophoresis onto 4% polyacrylamide stacking and 12%
polyacrylamide separating sodium dodecyl sulfate-polyacryl-
amide gel, and either stained with Coomassie brilliant blue
R250 (Bio-Rad) or transferred onto nylon membranes (Mid-
west Scientific, St. Louis, Mo.). After being washed with Tris-
buffered saline (TBS; pH 7.5) and blocked with 2% (wt/vol)
skim milk, the membranes were incubated with anti-digoxige-
nin sheep immunoglobulin G Fab fragments conjugated to
alkaline phosphatase (Roche) in blocking solution for 30 min
at room temperature. After being washed with TBS containing
0.1% (vol/vol) Tween 20, the membranes were equilibrated
with TBS containing 50 mM MgCl2 (pH 9.5) before incuba-
tion with chemiluminescent CSPD (disodium 3-(4-methoxy
spiro{1,2-dioxetane-3,2-[5-chloro]tricyclo[3.3.1.13,7]decan}-4-yl)
phenyl phosphate) substrate (Roche) for 1 min at room tem-
perature. The DIG-AMP reactive bands were resolved by ex-
posure of the membrane to X-OMAT-AR films (Eastman
Kodak Co., Rochester, N.Y.) for up to 10 min at room tem-
perature. In some experiments, nitroblue tetrazolium–5-bro-
mo-4-chloro-3-indolylphosphate (Bio-Rad Laboratories, Inc.,
Hercules, Calif.) was used as substrate.
Labeling of intact B. pilosicoli and E. coli cells with DIG-
AMP was accomplished by harvesting bacteria grown to expo-
nential growth phase and incubation with DIG-AMP (60 g)
for 30 min at 30°C. After incubation, whole-cell lysates or
membrane fractions were prepared as described above.
Initial studies with either intact cells or membrane prepara-
tions from E. coli confirmed previous findings (Fig. 1; 24).
When membrane preparations of the human B. pilosicoli were
incubated with DIG-AMP, two prominent bands with molec-
ular masses of approximately 94 and 62 kDa and less promi-
nent bands of approximately 42 and 22 to 25 kDa were found
(Fig. 1). Although several additional bands are seen when
membrane preparations from B. burgdorferi reacted with DIG-
AMP are exposed for longer period, up to 30 min (18), addi-
tional bands were not seen with B. pilosicoli exposed for up to
5 h (data not shown).
Both porcine B. pilosicoli strains had identical PBPs that
were slightly different from the human strain. Consistent with
the chemiluminescence assay, the nitroblue tetrazolium–5-bro-
mo-4-chloro-3-indolyl phosphate substrate revealed a promi-
nent 94-kDa band in each strain; however, all three strains had
a doublet of approximately 22 and 25 kDa. Instead of the 62-
and 42-kDa bands seen in the human strain, the two porcine
strains had bands of slightly higher molecular masses, of 68 and
50 kDa, respectively.
The low-molecular-mass (between 15 and 20 kDa) DIG-
AMP-reactive bands of E. coli are interpreted to represent
degradation products of HMW PBPs (9). Conversely, bands
with molecular masses of 21 kDa and of 13, 21, and 22 kDa,
identified in Helicobacter pylori (11) and B. burgdorferi (18),
respectively, have been assigned to PBPs. The low-molecular-
mass 22- and 25-kDa bands seen for B. pilosicoli might repre-
sent breakdown products of HMW PBPs rather than a low-
molecular-weight PBP. The absence of the 42-kDa band in
intact B. pilosicoli cells (Fig. 1A, lane 1) might be attributable
to a HMW PBP that is of low abundance, has a low affinity for
ampicillin, or both.
The therapeutic responses of patients with B. pilosicoli in-
fections and the in vitro sensitivities of B. pilosicoli to -lactam
antibiotics are consistent with the identification of PBPs in this
spirochete (2, 3, 13–15). The demonstration of PBPs in intact
B. pilosicoli cells suggests that the cell membrane is permeable
to -lactam antibiotics. Conversely, the resistance of B. pilosi-
coli to amoxicillin and the restoration of susceptibility by the
addition of clavulanic acid in a previous study (2) suggest that
-lactamase activity, rather than the ability of the drug to
penetrate the cell membrane, is the predominant resistance
mechanism in this spirochete. Consistent with these results
were the low MICs of B. pilosicoli to the -lactam antibiotics,
with enhanced resistance to inactivation by -lactamase, ceftri-
axone, and meropenem (2).
Because PBPs have endopeptidase and carboxypeptidase ac-
tivities, some of the PBPs identified in the present study might
be related to endopeptidases and to a carboxypeptidase iden-
tified in membrane preparations of B. pilosicoli in previous
studies (4, 17). The identification of PBPs of B. pilosicoli pro-
vides a basis for the characterization of the genes encoding
these proteins among pathogenic intestinal spirochetes of hu-
mans and animals.
This work was supported in part by funds provided by the USDA
Cooperative State Research, Education, and Extension Service (CS-
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FIG. 1. Results of chemiluminescence assays using whole-cell ly-
sates (A) and membrane preparations (B) of human B. pilosicoli strain
SP16 (lanes 1) and E. coli (lanes 2) reacted with ampicillin conjugated
to digoxigenin followed by immunoblot and chemiluminescence assays.
Two prominent PBPs with molecular masses of approximately 94 and
62 kDa and a minor 42-kDa reactive band present in B. pilosicoli
migrate at a position similar to the high-molecular-weight PBP-1 and
PBP-3 and the low-molecular-weight PBP-5/6 of E. coli. A less-defined
band, of approximately 22 to 25 kDa, that is present in the membrane
preparation of B. pilosicoli (panel B) but not in the intact cells (panel
A), might represent a breakdown product of high-molecular-weight
PBPs. MW, molecular weight in thousands.
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